The Role of Biopsy in the Assessment of Uveal Melanoma
By:  Mary E. Aronow, MD; Charles V. Biscotti, MD; Chan Chi-Chao, MD; Arun D. Singh, MD

CATT: Beyond Visual Acuity
By:  Frank Celia, Contributing Editor
Year 2 results did much more than just confirm that the two rival drugs are equivalent.

CATT, Meet IVAN
By:  Andrew Lotery, MD
What have we learned from the ongoing ranibizumab vs bevacizumab trials?

Ischemia and VEGF in Different Retinal Diseases and Therapies: How Does One Influence the Other?
By:  Michael A. Singer, MD; Darren J Bell, MD; Salman Porbandarwalla, MD

Combined CRVO Accompanied by Cilioretinal Artery Occlusion
By:  Stephen De Souza, MD; Shil Patel, MD

Controversies in Endophthalmitis Management
By:  Raj R. Rathod, MD; William F. Mieler, M.D.
Do the EVS guidelines still hold up in 2012?

The Bumpy Road to (EMR) Love
By:  Michael Engelbert, MD, PhD
Our chronicle of one practice’s EMR adoption.

Identifying Choroidal Pathology with Enhanced Depth Imaging OCT
By:  Jesse J Jung, MD; K. Bailey Freund, MD

Radiation Therapy in the Treatment of Exudative AMD
By:  Darius M. Moshfeghi, MD
Epimacular brachytherapy is still alive, and X-ray irradiation may provide yet another radiation modality for AMD.

RPS: From the Podium to the Practice
By:  Andrew E. Mathis, PhD, Medical Editor
The first in a series of articles covering the 2012 Retinal Physician Symposium.

Upfront: From the Editor-in-Chief
By:  Peter K. Kaiser, M.D.
Playing the numbers

Subspecialty News
Higher Lucentis dose in DME; Retinal adhesion may be key to CNV; Pain-relief after intravitreal injection; and more

Surgical Precision
By:  Steve Charles, MD, FACS, FICS
Considering hemostasis, retinopexy and PRP

Events Calendar

Coding Q&A
By:  Riva Lee Asbell
Using the eye codes for retina exams

Focus On
By:  Robert Murphy, Contributing Editor
This practice rotates around its axis

Clinical Trial Update